Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Gesellschaft epidemiologischen Krebsregister in Deutschland, Robert Koch-Institut (2013) Krebs in Deutschland 2009–2010. Häufigkeiten und Trends, 9. Aufl. Robert Koch-Institut, Berlin (in Deutschland)
2. Guentert TW (2015) Clinical Pharmacology Profile of Androgen – Directed Therapeutics Used in Prostate Cancer Therapy – Abiraterone (Zytigaâ) in Comparison to Alternative Products
3. IMS® LRx (2015) Co-Medication MAB. April 2015
4. Coca V, Nink K (2009) Arzneimittelverordnungen nach Alter und Geschlecht. In: Schwabe U, Paffrath D (Hrsg) Arzneiverordnungsreport 2009. Springer, Heidelberg, S 901–914
5. Nightingale G et al (2015) Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. J Clin Oncol 33(13):1453–1459
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Polypharmacy in Cancer Therapy;Chemotherapy Protocols and Infusion Sequence;2022
2. Drug-Drug Interactions in Prostate Cancer Treatment;Clinical Genitourinary Cancer;2020-04